Bristol Myers Squibb is seeking a Senior Director, MPL to lead the WW & US medical strategy for Mavacamten across all hypertrophic cardiomyopathy indications. The role requires directing the cross‑functional Asset/Indication Medical Strategy team and delivering integrated medical plans in a global context.
The successful candidate will engage global external experts, oversee evidence generation, and shape scientific communications while partnering with Discovery, Regulatory, and HEOR teams to
#J-18808-LjbffrGlobal Medical Strategy Lead, Mavacamten in nj at Unknown Company
This position is listed as full time and onsite.